Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eszopiclone in pediatric ADHD-associated insomnia
NCT00856973Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- May 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eszopiclone in Insomnia, sponsored by Sumitomo Pharma America. Started May 2009; status: completed.
02
Drugs
eszopiclone
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00856973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00856973.